Overview


According to FutureWise analysis, the market for Adenovirus Testing is expected to grow at a CAGR of 7.10% over the forecast period of 2023-2031.

Adenoviruses are non-enveloped, double-stranded deoxyribonucleic acid (DNA) viruses associated with various clinical syndromes in humans. More than fifty types of immunologically different adenoviruses can cause infections in humans. Adenovirus is resistant to common disinfectants and can be found on surfaces, such as doorknobs, small lakes, objects, and water in swimming pools. Adenoviruses most commonly cause respiratory illness. The illnesses can vary from the common cold to pneumonia, croup, and bronchitis. Depending on the type, adenoviruses can cause other illnesses such as gastroenteritis, cystitis, conjunctivitis, and, less commonly, neurological disease.

The approach to patients with adenovirus disease is complex. The optimal diagnostic strategy depends on the specific indication—screening asymptomatic patients versus diagnosing end-organ disease. Given the wide array of clinical presentations of adenovirus, it is necessary to consider the virus in immunocompromised patients with a compatible syndrome. Although there are limited treatment options, outcomes appear to be maximized when antiviral therapy is started before extensive disseminated disease is recognized. Throat swabs, nasal washes, conjunctival or scrapings, anal swabs, stool, urine, and blood may be collected for testing. Sample types collected and tested should correspond to clinically evident sites of infection (for example stool for GI disease, urine for genitourinary (GU) disease) 

FutureWise Market Research has published a report that provides an insightful analysis adenovirus testing market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, adenovirus testing market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Affymetrix
  • Agilent Technologies
  • Becton Dickinson and company
  • QIAGEN
  • Novartis AG
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • CTK Biotech Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Adenovirus Testing Market:

  • In July 2021- QIAGEN N.V. announced that its NeuMoDx™ HAdV Quant Assay secured identification and quantification CE-IVD certification for human adenovirus (HAdV) DNA testing for the European Union and other countries that accept this marking.

The rapid detection and quantification of adenovirus DNA, especially through PCR technique, is expected to be a significant driver in aiding the diagnosis and monitoring of adenovirus infections, particularly in immunocompromised individuals. The interpretation of PCR-based data has become an important issue in the clinical care of immunocompromised patients with suspected systemic adenoviral infection.PCR offers high sensitivity and specificity, allowing early and timely diagnosis. Additionally, monitoring adenovirus DNA levels during treatment helps assess treatment efficacy and disease progression, guiding healthcare providers in making treatment decisions for improved patient outcomes. Thus, the widespread adoption of PCR-based adenovirus testing is anticipated to positively impact patient management and overall healthcare outcomes in this vulnerable population. Furthermore, the lack of awareness about adenoviruses and their potential health impact in certain regions may significantly hinder the demand for adenovirus testing market. Insufficient knowledge about adenovirus infections may lead to underestimating or misdiagnosing related illnesses, delaying appropriate medical interventions. This lack of awareness can also impede healthcare providers' ability to recognize and respond promptly to outbreaks or epidemics, potentially worsening the spread of the virus. Therefore, educational initiatives and public awareness campaigns targeting these regions are crucial to improve awareness, increase testing rates, and enhance overall healthcare preparedness, eventually reducing the adverse effects of adenovirus infections in vulnerable populations.

By Assay

  • PCR Assay Kits
  • Antigen Detection Kits
  • Other Assay Kits

By Diagnostic Technique

  • Polymerase Chain Reaction (PCR)
  • Antigen Based Assay
  • Monoclonal Antibodies
  • Chromatography
  • Virus Culture
  • Liposomes And Flow Cytometry
  • Gel Microdroplets

By End User

  • Hospitals
  • Clinics
  • Diagnostic Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. North America is expected to gain significant traction due to growing public health concerns regarding various infectious diseases, such as pneumonia associated with adenovirus infection. For instance, the National Center for Health Statistics reported that the eighth cause of mortality in the United States was influenza and pneumonia together. Manufacturers offer a variety of immunoassays for the detection of adenovirus antigens. The SD BIOLINE Rota / Adeno Ag test is one of Abbott's immunochromatographic analyses that qualitatively detect the presence of rotavirus or adenovirus antigens in human feces specimens.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Adenovirus Testing Market By Assay, By Diagnostic Techniques, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customisation offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.  Adenovirus Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Adenovirus Testing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Adenovirus Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Adenovirus Testing Market, By Assay Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. PCR Assay Kits
        2. Antigen Detection Kits
        3. Other Assay Kits

  • 8.  Adenovirus Testing Market, By Diagnostic Technique Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Polymerase Chain Reaction (PCR)
        2. Antigen Based Assay
        3. Monoclonal Antibodies
        4. Chromatography
        5. Virus Culture
        6. Liposomes And Flow Cytometry
        7. Gel Microdroplets

  • 9.  Adenovirus Testing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Diagnostic Laboratories

  • 10.   North America Adenovirus Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Adenovirus Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Adenovirus Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Adenovirus Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Adenovirus Testing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Affymetrix
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Agilent Technologies
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Becton Dickinson and company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. QIAGEN
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Novartis AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad Laboratories Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. F. Hoffmann-La Roche Ltd.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Abbott Laboratories
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. CTK Biotech Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Adenovirus Diagnostic Testing Market

Read More
Partner

Our Clients